Patrick Lamy, Senior VP, Commercial Strategy: Akero Therapeutics AKRO Sell · Filed 24/06/13

Trade details

Type: Insider sale
Amount: $12,882.16
Shares · price: 569 sh · $22.64 a share
Held after: 18,562 sh
Stock: Akero Therapeutics AKRO
Person: Patrick LamySenior VP, Commercial Strategy
Trade date: 24/06/11
Filed: 24/06/13
Days to filing: 2 days

Sold 3.0% of holdings

Share of holding sold: 3.0%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/12~24/07/11

Patrick Lamy's recent trades

Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$105.8K
2,000 sh
$105.8K
Filed 25/07/03
Traded 25/07/01
Patrick LamySenior VP, Commercial Strategy
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$47.8K
875 sh
$47.8K
Filed 25/06/20
Traded 25/06/20
Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$80.7K
1,500 sh
$80.7K
Filed 25/06/20
Traded 25/06/16
Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$27.5K
500 sh
$27.5K
Filed 25/06/20
Traded 25/06/16
Patrick LamySenior VP, Commercial Strategy
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$49.6K
919 sh
$49.6K
Filed 25/06/12
Traded 25/06/10